TABLE 4.
Comparison of ACVR2B rs2276541 polymorphism between healthy controls and the sarcopenia group
| Group | Genotype (%) | Allele (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AA | AG | GG | χ 2 | p 1 | A | G | χ 2 | p 2 | |
| Sarcopenia | 24 (30.0) | 36 (45.0) | 20 (25.0) | 0.436 | 0.804 | 84 (52.5) | 76 (47.5) | 0.050 | 0.823 |
| S‐Male | 12 (30.0) | 17 (42.5) | 11 (27.5) | 1.310 | 0.519 | 41 (51.25) | 39 (48.75) | 0.100 | 0.752 |
| S‐Female | 12 (30.0) | 19 (47.5) | 9 (22.5) | 0.857 | 0.651 | 45 (56.25) | 35 (43.75) | 1.601 | 0.206 |
| Control | 21 (26.25) | 40 (50.0) | 19 (23.75) | — | — | 82 (51.25) | 78 (48.75) | — | — |
| C‐Male | 12 (30.0) | 21 (52.5) | 7 (17.5) | — | — | 43 (53.75) | 37 (46.25) | — | — |
| C‐Female | 9 (22.5) | 19 (47.5) | 12 (30.0) | — | — | 37 (46.25) | 43 (53.75) | — | — |